-
Thematic Analysis
NewOil and Gas M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Oil & Gas Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Futibatinib in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Futibatinib in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Futibatinib in Solid Tumor Drug Details: Futibatinib (Lytgobi) is an anticancer...
-
Product Insights
Taichung Harbor
Taichung Harbor is an Onshore Wind project located in Taichung, Taiwan. The project is owned and developed by Taiwan Power Co Ltd. The project came online in 2006. Empower your strategies with our Taichung Harbor report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...
-
Product Insights
Ice Harbor
Ice Harbor is a Hydro project located in Washington, United States. The project is owned by US Army Corps of Engineers. The project came online in 1961. Empower your strategies with our Ice Harbor report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...
-
Product Insights
Safe Harbor
Safe Harbor is a Hydro project located in Pennsylvania, United States. The project is owned by Brookfield Renewable Partners LP and was developed by Safe Harbor Water Power Corp. The project came online in 1931. Empower your strategies with our Safe Harbor report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Futibatinib in Esophageal Squamous Cell Carcinoma (ESCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Futibatinib in Esophageal Squamous Cell Carcinoma (ESCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Futibatinib in Esophageal Squamous Cell Carcinoma (ESCC) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Futibatinib in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Futibatinib in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Futibatinib in Gastric Cancer Drug Details: Futibatinib (Lytgobi) is an anticancer...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Futibatinib in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Futibatinib in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Futibatinib in Metastatic Breast Cancer Drug Details: Futibatinib (Lytgobi) is an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Futibatinib in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Futibatinib in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Futibatinib in Triple-Negative Breast Cancer (TNBC) Drug Details: Futibatinib (Lytgobi)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Futibatinib in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Futibatinib in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Futibatinib in Transitional Cell Carcinoma (Urothelial Cell...